H101 is an E1B/E3B-deleted adenovirus that restricts p53-mutated neoplasm replication, sparing p53 wild-type tissues.39 The decreased cancer-specific mortality for HCC patients treated with combined TACE and H101 therapy compared with TACE therapy alone may be explained by the following mechanism. Here, TP53 is linked to hepatocellular carcinoma.